Mary Buckwalter

674 total citations
14 papers, 543 citations indexed

About

Mary Buckwalter is a scholar working on Pharmacology, Psychiatry and Mental health and Infectious Diseases. According to data from OpenAlex, Mary Buckwalter has authored 14 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 4 papers in Psychiatry and Mental health and 3 papers in Infectious Diseases. Recurrent topics in Mary Buckwalter's work include Attention Deficit Hyperactivity Disorder (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Systemic Lupus Erythematosus Research (3 papers). Mary Buckwalter is often cited by papers focused on Attention Deficit Hyperactivity Disorder (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Systemic Lupus Erythematosus Research (3 papers). Mary Buckwalter collaborates with scholars based in United States, France and Canada. Mary Buckwalter's co-authors include James A. Dowell, Elyse Seltzer, James Ermer, Honghui Zhou, Thomas Marbury, Joan Korth‐Bradley, David P. Nicolau, Patrick Martin, Dong‐Seok Yim and Carl C. Peck and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, Critical Care and Journal of Clinical Psychopharmacology.

In The Last Decade

Mary Buckwalter

14 papers receiving 520 citations

Peers

Mary Buckwalter

PHARM

PMH

PPCH

Salim Hadad Israel

Danny Benjamin United States

Silvia E. Schliamser Sweden

Minne Casteels Belgium

Shingo Yamazaki Japan

Nabanita Ghosh India

Sara Marquis United States

D J Brazier United Kingdom

Shengyuan Liu China

Martin Kankam United States

Salim Hadad Israel

Mary Buckwalter

80 ×0.4

63 ×0.4

PHARM

108 ×0.9

PMH

32 ×0.3

146 ×2.5

PPCH

Citations per year, relative to Mary Buckwalter Mary Buckwalter (= 1×) peers Salim Hadad

Countries citing papers authored by Mary Buckwalter

Since Specialization

Citations

This map shows the geographic impact of Mary Buckwalter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Buckwalter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Buckwalter more than expected).

Fields of papers citing papers by Mary Buckwalter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Buckwalter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Buckwalter. The network helps show where Mary Buckwalter may publish in the future.

Co-authorship network of co-authors of Mary Buckwalter

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Buckwalter. A scholar is included among the top collaborators of Mary Buckwalter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Buckwalter. Mary Buckwalter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Ermer, James, W Döll, Erik P. Sandefer, et al.. (2011). Intranasal versus Oral Administration of Lisdexamfetamine Dimesylate. Clinical Drug Investigation. 31(6). 357–370. 31 indexed citations

Ermer, James, Mary Buckwalter, & Patrick Martin. (2011). P.7.c.002 Low variability in exposure to d-amphetamine in children and adults after administration of lisdexamfetamine dimesylate. European Neuropsychopharmacology. 21. S605–S605. 1 indexed citations

Pierce, David M., et al.. (2010). Single- and Multiple-Dose Pharmacokinetics of Methylphenidate Administered as Methylphenidate Transdermal System or Osmotic-Release Oral System Methylphenidate to Children and Adolescents With Attention Deficit Hyperactivity Disorder. Journal of Clinical Psychopharmacology. 30(5). 554–564. 16 indexed citations

Ermer, James, et al.. (2010). Lisdexamfetamine Dimesylate: Linear Dose‐Proportionality, Low Intersubject and Intrasubject Variability, and Safety in an Open‐Label Single‐Dose Pharmacokinetic Study in Healthy Adult Volunteers. The Journal of Clinical Pharmacology. 50(9). 1001–1010. 64 indexed citations

Marbury, Thomas, James A. Dowell, Elyse Seltzer, & Mary Buckwalter. (2009). Pharmacokinetics of Dalbavancin in Patients With Renal or Hepatic Impairment. The Journal of Clinical Pharmacology. 49(4). 465–476. 63 indexed citations

Buckwalter, Mary, et al.. (2009). Effects of Omeprazole on the Pharmacokinetic Profiles of Lisdexamfetamine Dimesylate and Extended-Release Mixed Amphetamine Salts in Adults. Postgraduate Medicine. 121(5). 11–19. 29 indexed citations

Dowell, James A., Beth P. Goldstein, Mary Buckwalter, Martin Stogniew, & Bharat Damle. (2008). Pharmacokinetic‐Pharmacodynamic Modeling of Dalbavancin, a Novel Glycopeptide Antibiotic. The Journal of Clinical Pharmacology. 48(9). 1063–1068. 36 indexed citations

Dowell, James A., et al.. (2008). The pharmacokinetics of dalbavancin in subjects with mild, moderate, or severe hepatic impairment. Critical Care. 12(Suppl 2). P25–P25. 5 indexed citations

Nicolau, David P., et al.. (2007). Pharmacokinetics of dalbavancin in plasma and skin blister fluid. Journal of Antimicrobial Chemotherapy. 60(3). 681–684. 54 indexed citations

10.

Buckwalter, Mary & James A. Dowell. (2005). Population Pharmacokinetic Analysis of Dalbavancin, a Novel Lipoglycopeptide. The Journal of Clinical Pharmacology. 45(11). 1279–1287. 88 indexed citations

11.

Yim, Dong‐Seok, Honghui Zhou, Mary Buckwalter, et al.. (2005). Population Pharmacokinetic Analysis and Simulation of the Time‐Concentration Profile of Etanercept in Pediatric Patients With Juvenile Rheumatoid Arthritis. The Journal of Clinical Pharmacology. 45(3). 246–256. 59 indexed citations

12.

Zhou, Honghui, Alain Patat, Virginia Parks, et al.. (2004). Absence of a Pharmacokinetic Interaction between Etanercept and Warfarin. The Journal of Clinical Pharmacology. 44(5). 543–550. 31 indexed citations

13.

Buckwalter, Mary, James A. Dowell, Joan Korth‐Bradley, Boris Gorovits, & Philip R. Mayer. (2004). Pharmacokinetics of Gemtuzumab Ozogamicin as a Single‐Agent Treatment of Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia. The Journal of Clinical Pharmacology. 44(8). 873–880. 41 indexed citations

14.

Zhou, Honghui, Mary Buckwalter, Joseph Boni, et al.. (2004). Population-based pharmacokinetics of the soluble TNFr etanercept: a clinical study in 43 patients with ankylosing spondylitis compared with post hoc data from patients with rheumatoid arthritis. International Journal of Clinical Pharmacology and Therapeutics. 42(5). 267–276. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact